April 14, 2023

Upcoming Events

Constructive Collisions: ARPA-H 

Does the idea of high-potential, high-impact health research excite you? Do you have a $10 million - $30 million idea that could transform biomedical and health research?  

If so, join us for an in-person, on-campus event that will include structured networking opportunities to connect researchers with big ideas relevant to ARPA-H across the Emory community. No idea is too big for ARPA-H. All interested Emory researchers are encouraged to attend. 


The first Mission Office Directors and Program Managers have been named. Click the links below to find out more about these key ARPA-H team members.  

For more information on ARPA-H focus areas, visit the ARPA-H Research page.   

Date: April 20, 2023

Time: 12-2 pm

Location: R. Randall Rollins Building, 8th Floor 1518 Clifton Rd. NE Atlanta, 30322

Registration for this event closes April 17th.  Parking and box lunches included.


If you have questions or suggestions for a Constructive Collisions event, contact the Office of Research Development, researchdevelopment@emory.edu 



Advanced Research Projects Agency for Health (ARPA-H) Open-Office Broad Agency Announcement (BAA)

The Advanced Research Projects Agency for Health (ARPA-H) is issuing the ARPA-H Open Office Broad Agency Announcement (BAA). ARPA-H’s mission is to accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society's most challenging health problems.

Awardees will develop groundbreaking new ways to tackle health-related challenges through high-potential, high-impact biomedical and health research. With a scope spanning the molecular to the societal, ARPA-H seeks proposals that aim to rapidly achieve better health outcomes across patient populations, communities, diseases, and health conditions, including in support of the Cancer Moonshot. 

Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, or systems. The four initial focus areas are:


(1) Health Science Futures;


(2) Scalable Solutions;


(3) Proactive Health;


(4) Resilient Systems;


Please see the BAA and associated attachments for further details. Inquiries may be sent to ARPA-HBAAQuestions@ARPA-H.gov

More Information

Featured Opportunities

Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites applications for the Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform initiative.

This Platform aims to transform the AD/ADRD research enterprise by serving as a central hub of research access that seeks to: 1) improve applicability and generalizability of findings through larger datasets that include more diverse populations; 2) capture more complete information through linking a variety of data sources; 3) increase the speed at which scientific questions can be answered; and 4) improve researchers’ ability to answer questions that cannot be feasibly or readily answered via clinical trial.

Deadline: 7/31/2023

More information

Agency for Healthcare Research and Quality (AHRQ) Interest in Research on Climate Change and Healthcare

AHRQ has a special interest in receiving health services research grant applications that address the intersection of climate change and healthcare. Applications that address the following areas are of heightened interest:

  • Reducing the healthcare sector’s greenhouse gas emissions and carbon footprint.
  • Creating resilient healthcare systems and communities that can plan, prepare, respond, and adapt to climate-related threats.
  • Addressing the inequitable impacts of climate change.


Climate change is the leading threat to public health, contributing to both individual health problems and broader disruptions to vital infrastructure and the healthcare system.


The healthcare industry is not only a responder to climate events, but a significant contributor to climate change through its emissions.


Research and action are needed on both fronts and must be guided by an equity lens that prioritizes protecting and empowering individuals and communities that face the highest risks and bear the highest burdens of environmental pollution and a changing climate.


Applications in these areas are being accepted through multiple programs. 

Deadline for applications vary based on program

View Announcement

Oak Ridge Associated Universities (ORAU)

ORAU’s FY 2023 Innovation Partnerships Program (formerly Events Sponsorship Grant Program) is being restructured. The goal of this grant program change is to drive new opportunities for university consortium members and ORAU experts to formulate meaningful collaborations. Applications must be focused on one or more of the FY2023 ORAU core focus areas:


  • Climate and Environment
  • Health Equity
  • Future of STEM Workforce


Innovation Partnership applications should focus on focused workshops/conferences that highlight your university’s strategic STEM research and education growth areas, and where collaborations with other member universities would add value.


We are specifically interested in events that can bring more thought leadership in building a national strategy for STEM education and workforce development. 

Applications accepted anytime

View Guidelines


National Institutes of Health (NIH):

Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care

The purpose of this opportunity is to propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care.

This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.

Deadline: 6/16/2023

National Institutes of Health:

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (PAR-23-119)

The purpose of this opportunity is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.

Deadline: 6/16/2023

Infectious Disease

National Institutes of Health (NIH): Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18)(RFA-HS-23-012)

The purpose of this opportunity is to expand access to comprehensive, coordinated, and person-centered care for people with Long COVID, particularly underserved, rural, vulnerable, or minority populations that are disproportionately impacted by the effects of Long COVID. 

Deadline: 6/12/2023

National Institutes of Health (NIH): Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed)(RFA-AI-23-018)

Encourages research focused on defining the molecular mechanisms by which HIV proteins and/or nucleic acids induce inflammation, immune activation and HIV persistence during viral suppression as well as on developing novel therapeutic strategies to mitigate or eliminate the effects of continued HIV expression. 

AIDS Deadline: 8/2/2023

Brain Health

National Institutes of Health (NIH):

Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) (RFA-NS-23-022)

The purpose of this opportunity is to invite exploratory and innovative research applications focused on the neurological and neuropsychiatric manifestations of COVID-19 (neuro-COVID) and Post-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions.

Deadline: 6/2/2023

National Institutes of Health (NIH):

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) (RFA-DC-24-001)

Invasive surgical procedures offer the opportunity for unique intracranial interventions such as the ability to record and stimulate intracranially within precisely localized brain structures in humans. 

Deadline: 9/22/2023


National Institutes of Health (NIH):

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)(PAR-22-165)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication pilot interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. 

Deadline: 6/16/2023

National Institutes of Health (NIH): Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)(RFA-CA-22-029)

Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate development, innovation and establishment of adoptive cellular therapy clinical trials for treatment of pediatric patients (18 years or younger) with solid tumors.

Specifically, UG3 phase of the awards will support preclinical, translational and IND-enabling studies that lay groundwork for UH3 early stage clinical trials testing adoptive immune cell therapies in pediatric patients with solid tumors.

Deadline: 6/30/2023

Global Health

National Institutes of Health (NIH):

Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)

The purpose of this opportunity is to investigate the potential health risks of environmental exposures of concern to a community and to develop and implement an environmental public health action plan based on research findings.

Deadline: 6/5/2023

National Science Foundation:

Macrosystems Biology and NEON-Enabled Science (MSB-NES)(NSF 22-504)

The Macrosystems Biology and NEON-Enabled Science (MSB-NES): Research on Biological Systems at Regional to Continental Scales program will support quantitative, interdisciplinary, systems-oriented research on biosphere processes and their complex interactions with climate, land use, and changes in species distribution at regional to continental scales as well as training activities to broaden participation of researchers in Macrosystems Biology and NEON-Enabled Science.

Deadline: 11/13/2023

Social Justice / DEI

National Institutes of Health (NIH):

Advancing Gender Inclusive Excellence (AGIE) – Coordinating Center (U24 Clinical Trial Not Allowed)(RFA-OD-23-004)

The purpose of this opportunity is to promote a new initiative by reissuing RFA-OD-21-010, "Advancing Gender Inclusive Excellence (AGIE) – Coordinating Center (U54 Clinical Trial Not Allowed)" to invite applications for an Advancing Gender Inclusive Excellence (AGIE) – Coordinating Center (U24 – Clinical Trial Not Allowed).

Deadline: 5/31/2023

National Institutes of Health (NIH):   

The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)(PAR-21-275)

This purpose of this opportunity is to support innovative population-based research that can contribute to identifying and characterizing pathways and mechanisms through which work or occupation influences health outcomes and health status among populations with health and/or health care disparities, and how work functions as a social determinant of health.

Deadline: 6/5/2023

Finding Funding

Funding Opportunities Calendar 

A comprehensive archive of past, present, and upcoming opportunities can be found on the SVPR funding calendar. Click the link below to view.

Link to SVPR Funding Calendar

Limited and Internal Competitions through InfoReady

Universities involved in research often need to run competitions for grant funding, whether for internal grant dollars or limited submission opportunities through external sponsors.

If you are interested in submitting a proposal to a funding opportunity with an institutional limitation, please check InfoReady to see if it is listed first. If it is not there, please email limited-opps@emory.edu and include the funding opportunity number, title, and due date.

Link to InfoReady

Search Tool for Corporate and Foundation Funding Opportunities

The Office of Corporate Relations and the Office of Foundation Relations have teamed up to create this resource site to provide a curated list of current funding opportunities and other resources. This site will help promote connections between Emory colleagues and corporate/foundation partners.

Link to SharePoint Search Tool


Free access available with Emory Email address. Formally IRIS. Provides access to the University Community to conduct funding searches. The database is provides funding opportunities for the physical and life sciences, social sciences, arts, and humanities.

Link for More Information


Grants.gov is a central storehouse for information on over 1,000 grant programs from over 27 federal agencies. Interested applicants can search for relevant funding opportunities by Keyword or Category or browse opportunities by agency. The portal is also a central source to apply for federal grants. Information on the processes for proposal submission through Grants.gov can be found in Proposal Submission.

Foundation Directory

Free access available through Databases@Emory. This database, produced by the nation's leading authority on philanthropy, includes extensive program details for thousands of leading foundations; detailed application guidelines for more than 7,000 grants; and a searchable file of approximately half a million grants.

Link for More Information

Visit our website